Brain Rhythm Predicts Response to DBS for Severe Depression
November 24, 2021   

Deep brain stimulation of the subcallosal cingulate may be a promising intervention for treatment-resistant depression. While one clinical file failed, multiple case series have reported positive results, especially since surgical procedures for it have improved. Recent evidence suggests that...
 Continue reading (Members only)
Subthreshold PTSD Prevalent and Associated With Substantial Clinical Burden in Older U.S. Veterans
November 22, 2021   

Subthreshold posttraumatic stress disorder (PTSD) is characterized by clinically significant PTSD symptoms below the threshold for diagnosis. It is not recognized as a diagnostic entity and is less well studied in older adults, despite its higher prevalence and potential clinical significance. In older adults, PTSD is associated with worse physical, cognitive, and social functioning, as well as...
 Continue reading (Members only)
Psilocybin Therapy Increases Cognitive And Neural Flexibility In Patients With Major Depressive Disorder
November 18, 2021   

Psilocybin therapy has shown promise in treating major depressive disorder and other psychiatric illnesses. However, the cognitive and neural mechanisms underlying its enduring efficacy is poorly understood. An open-label study examined the enduring effects of psilocybin therapy on the cognitive and neural flexibility...
 Continue reading
Telehealth Treatment of Patients With Borderline Personality Disorder Safe and Effective
November 15, 2021   

The first study reporting on the comparative efficacy, acceptability, and safety of in-person and telehealth partial hospital program services for patients with borderline personality disorder was published recently in...
 Continue reading (Members only)
2021 NEI Congress Taking a Bite Out of Nutrition and Mental Health
November 7, 2021   

During the 2021 NEI Congress, Dr. Andrew Cutler presented a fascinating lecture on the influence of nutrition on mental health. He presented metabolic contributors to mental illness, along with an examination of the role that inflammation, and specific diets play in mental health. Possible contributors to mental illness are..
 Continue reading
2021 NEI Congress Interview with the Author of Hidden Valley Road
November 6, 2021   

This very special event at the 2021 NEI Congress featured Robert Kolker, author of the New York Times bestseller and Oprah’s Book Club pick “Hidden Valley Road”. “Hidden Valley Road” is the true story of the Galvin family, a Colorado Springs family with 12 children, 6 of whom were diagnosed with schizophrenia. ...
 Continue reading
2021 NEI Congress Young Investigator Poster Competition Winners
November 5, 2021   

The 2021 NEI Congress Scientific Poster Session and Reception was held on Friday, November 5th and featured 67 posters, with an additional 48 posters presented virtually, covering the full spectrum of mental health research and clinical data. Among them, three particularly stood out for the quality of their data and contributions to the field, and...
 Continue reading
2021 NEI Congress Recreational Drug Use Workshop
November 4, 2021   

The 2021 NEI Congress kicked off with a pre-conference workshop on recreational drugs—both as illicit agents and as potential therapeutic options. Roger S. McIntyre, MD, FRCPC began the workshop with “An Update on Psychedelics,” explaining both the historical use of these agents as therapeutic entities as well as the scientific rationale for the renewed interest in psychedelic-assisted therapy as a treatment paradigm. At present...
 Continue reading
2021 NEI Congress Child & Adolescent Psychiatry Academy
November 3, 2021   

The 2021 NEI Congress is off to a strong start with the 5th Child and Adolescent Psychiatry Academy. Dr. Jeffrey Strawn opened the Academy with a topic of utmost importance as of late, pediatric anxiety. In this session...
 Continue reading
Wide Racial and Geographic Disparities Found in Clozapine and LAI Prescriptions
October 29, 2021   

Treatment variation refers to differences in treatment that are not attributable to differences in clinical presentations for persons with the same condition. These variations may be due to uncertainty by prescribing clinicians, variations in health insurance benefits, patient preferences, and inequities due to socioeconomic status, race, or ethnicity...
 Continue reading (Members only)
Top of Page